Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway.
Ruozhi DangMingyang WangXinhui LiHaiyang WangLanxiang LiuQingyuan WuJianting ZhaoPing JiLianmei ZhongJulio LicinioPeng XiePublished in: Journal of neuroinflammation (2022)
These findings suggest that EDA possesses potent antidepressant and anxiolytic properties through Sirt1/Nrf2/HO-1/Gpx4 axis and Gpx4-mediated ferroptosis may play a key role in this effect.